<p>Ranger Investment Management L.P. 在最近向證券交易委員會（SEC）提交的文件中表示，在第二季度減少了對 Mesa Laboratories, Inc.（NASDAQ:MLAB - 免費報告）7.2% 的持股。該公司在本季度出售了 16,698 股後，持有 214,290 股這家醫療儀器供應商的股票。Ranger Investment Management L.P. 在最近一個季度末持有的 Mesa Laboratories 的股份佔比為 3.89%，價值為 20,190,000 美元。</p>
<p>獲取 <strong>Mesa Laboratories</strong> 的提醒：</p>
<p>其他一些機構投資者最近也增加或減少了對 MLAB 的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度將其在 Mesa Laboratories 的持股增加了 4.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 3,068 股這家醫療儀器供應商的股票，價值為 364,000 美元，此前在該期間購買了 143 股。Franklin Resources Inc. 在第二季度將其在 Mesa Laboratories 的持股增加了 5.5%。Franklin Resources Inc. 目前持有 3,476 股這家醫療儀器供應商的股票，價值為 328,000 美元，此前在上個季度購買了 182 股。American Century Companies Inc. 在第二季度將其在 Mesa Laboratories 的持股增加了 1.5%。American Century Companies Inc. 目前持有 13,431 股這家醫療儀器供應商的股票，價值為 1,265,000 美元，此前在該期間購買了 194 股。阿拉斯加州財政部在第二季度將其在 Mesa Laboratories 的持股增加了 7.1%。阿拉斯加州財政部目前持有 3,224 股這家醫療儀器供應商的股票，價值為 303,000 美元，此前在上個季度購買了 213 股。最後，加拿大皇家銀行在第一季度將其在 Mesa Laboratories 的持股增加了 1.2%。加拿大皇家銀行目前持有 30,772 股這家醫療儀器供應商的股票，價值為 3,652,000 美元，此前在該期間購買了 353 股。機構投資者和對沖基金持有該公司 90.60% 的股份。</p>
<h2>Mesa Laboratories 股價下跌 1.1%</h2>
<p>Mesa Laboratories 的股票在週五開盤價為 77.77 美元。該公司的市值為 4.2929 億美元，市盈率為-243.03，貝塔係數為 0.90。Mesa Laboratories, Inc. 的一年最低價為 55.45 美元，一年最高價為 155.12 美元。該公司的 50 日移動平均價格為 75.50 美元，200 日移動平均價格為 77.92 美元。該公司的債務與股本比率為 0.95，速動比率為 1.44，流動比率為 2.02。</p>
<h2>Mesa Laboratories 分紅公告</h2>
<p>該公司最近宣佈了季度分紅，將於 12 月 15 日（星期一）支付。11 月 28 日（星期五）登記的投資者將獲得 0.16 美元的分紅。除息日為 11 月 28 日（星期五）。這代表着年化分紅為 0.64 美元，分紅收益率為 0.8%。Mesa Laboratories 的分紅支付比率（DPR）為-200.00%。</p>
<h2>華爾街分析師預測增長</h2>
<p>一些研究分析師最近對 MLAB 股票發表了評論。華爾街 Zen 在 11 月 8 日（星期六）的研究報告中將 Mesa Laboratories 的股票評級從 “持有” 上調至 “買入”。Weiss Ratings 在 10 月 8 日（星期三）的研究報告中重申了對 Mesa Laboratories 股票的 “賣出（d）” 評級。最後，Zacks Research 在週四將 Mesa Laboratories 的評級上調至 “強烈賣出”。一位投資分析師對該股票給予了 “持有” 評級，兩位分析師對該股票給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Mesa Laboratories 目前的平均評級為 “賣出”，共識目標價為 67.00 美元。</p>
<p><strong>獲取我們對 Mesa Laboratories 的最新股票分析</strong></p>
<h2>Mesa Laboratories 公司簡介</h2>
<p>（免費報告）</p>
<p>Mesa Laboratories, Inc. 在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、去污、消毒和清潔過程的有效性。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Mesa Laboratories</li>
<li>動量投資與長期投資的區別</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
<li>擁有債券的風險</li>
<li>為什麼亞馬遜可能在幾周內成為 300 美元的股票</li>
<li>即將到來的 IPO 股票鎖定期，解釋</li>
<li>Adobe 在財報後獲得提振：長期前景看好</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在 Mesa Laboratories 嗎？</h2>
<p>在你考慮投資 Mesa Laboratories 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前立即購買……而 Mesa Laboratories 並不在名單上。</p>
<p>雖然 Mesa Laboratories 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

MLAB

<p>Ranger Investment Management L.P. 在第二季度減少了對 Mesa Laboratories, Inc. 的持股，降幅為 7.2%，目前持有該公司 3.89% 的股份。Mesa Laboratories 的股票開盤價為 77.77 美元，市值為 4.2929 億美元。分析師的評級意見不一，普遍目標價為 67.00 美元。該公司宣佈季度股息為 0.16 美元，將於 12 月 15 日支付</p>

<p>Ranger Investment Management L.P. reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 7.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 214,290 shares of the medical instruments supplier's stock after selling 16,698 shares during the quarter. Ranger Investment Management L.P. owned 3.89% of Mesa Laboratories worth $20,190,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Ranger Investment Management L.P. 在最近向證券交易委員會（SEC）提交的文件中表示，在第二季度減少了對 Mesa Laboratories, Inc.（NASDAQ:MLAB - 免費報告）7.2% 的持股。該公司在本季度出售了 16,698 股後，持有 214,290 股這家醫療儀器供應商的股票。Ranger Investment Management L.P. 在最近一個季度末持有的 Mesa Laboratories 的股份佔比為 3.89%，價值為 20,190,000 美元。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Mesa Laboratories</strong> 的提醒：</p>
</div><p>A number of other institutional investors also recently added to or reduced their stakes in MLAB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Mesa Laboratories by 4.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,068 shares of the medical instruments supplier's stock valued at $364,000 after purchasing an additional 143 shares during the period. Franklin Resources Inc. grew its position in Mesa Laboratories by 5.5% in the 2nd quarter. Franklin Resources Inc. now owns 3,476 shares of the medical instruments supplier's stock valued at $328,000 after buying an additional 182 shares in the last quarter. American Century Companies Inc. increased its stake in Mesa Laboratories by 1.5% during the 2nd quarter. American Century Companies Inc. now owns 13,431 shares of the medical instruments supplier's stock valued at $1,265,000 after buying an additional 194 shares during the period. State of Alaska Department of Revenue raised its position in shares of Mesa Laboratories by 7.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,224 shares of the medical instruments supplier's stock worth $303,000 after buying an additional 213 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in shares of Mesa Laboratories by 1.2% in the 1st quarter. Royal Bank of Canada now owns 30,772 shares of the medical instruments supplier's stock worth $3,652,000 after acquiring an additional 353 shares during the period. Institutional investors and hedge funds own 90.60% of the company's stock.</p>
<div class="lb-trans"><p>其他一些機構投資者最近也增加或減少了對 MLAB 的持股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度將其在 Mesa Laboratories 的持股增加了 4.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 3,068 股這家醫療儀器供應商的股票，價值為 364,000 美元，此前在該期間購買了 143 股。Franklin Resources Inc. 在第二季度將其在 Mesa Laboratories 的持股增加了 5.5%。Franklin Resources Inc. 目前持有 3,476 股這家醫療儀器供應商的股票，價值為 328,000 美元，此前在上個季度購買了 182 股。American Century Companies Inc. 在第二季度將其在 Mesa Laboratories 的持股增加了 1.5%。American Century Companies Inc. 目前持有 13,431 股這家醫療儀器供應商的股票，價值為 1,265,000 美元，此前在該期間購買了 194 股。阿拉斯加州財政部在第二季度將其在 Mesa Laboratories 的持股增加了 7.1%。阿拉斯加州財政部目前持有 3,224 股這家醫療儀器供應商的股票，價值為 303,000 美元，此前在上個季度購買了 213 股。最後，加拿大皇家銀行在第一季度將其在 Mesa Laboratories 的持股增加了 1.2%。加拿大皇家銀行目前持有 30,772 股這家醫療儀器供應商的股票，價值為 3,652,000 美元，此前在該期間購買了 353 股。機構投資者和對沖基金持有該公司 90.60% 的股份。</p>
</div><h2>Mesa Laboratories Trading Down 1.1%</h2>
<div class="lb-trans"><h2>Mesa Laboratories 股價下跌 1.1%</h2>
</div><p>Mesa Laboratories stock opened at $77.77 on Friday. The firm has a market cap of $429.29 million, a price-to-earnings ratio of -243.03 and a beta of 0.90. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $155.12. The firm's 50 day moving average price is $75.50 and its two-hundred day moving average price is $77.92. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.44 and a current ratio of 2.02.</p>
<div class="lb-trans"><p>Mesa Laboratories 的股票在週五開盤價為 77.77 美元。該公司的市值為 4.2929 億美元，市盈率為-243.03，貝塔係數為 0.90。Mesa Laboratories, Inc. 的一年最低價為 55.45 美元，一年最高價為 155.12 美元。該公司的 50 日移動平均價格為 75.50 美元，200 日移動平均價格為 77.92 美元。該公司的債務與股本比率為 0.95，速動比率為 1.44，流動比率為 2.02。</p>
</div><h2>Mesa Laboratories Dividend Announcement</h2>
<div class="lb-trans"><h2>Mesa Laboratories 分紅公告</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 28th will be given a $0.16 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.8%. Mesa Laboratories's dividend payout ratio (DPR) is -200.00%.</p>
<div class="lb-trans"><p>該公司最近宣佈了季度分紅，將於 12 月 15 日（星期一）支付。11 月 28 日（星期五）登記的投資者將獲得 0.16 美元的分紅。除息日為 11 月 28 日（星期五）。這代表着年化分紅為 0.64 美元，分紅收益率為 0.8%。Mesa Laboratories 的分紅支付比率（DPR）為-200.00%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>A number of research analysts recently commented on MLAB shares. Wall Street Zen upgraded shares of Mesa Laboratories from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Mesa Laboratories in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded Mesa Laboratories to a &#34;strong sell&#34; rating in a report on Thursday. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Mesa Laboratories currently has an average rating of &#34;Sell&#34; and a consensus target price of $67.00.</p>
<div class="lb-trans"><p>一些研究分析師最近對 MLAB 股票發表了評論。華爾街 Zen 在 11 月 8 日（星期六）的研究報告中將 Mesa Laboratories 的股票評級從 “持有” 上調至 “買入”。Weiss Ratings 在 10 月 8 日（星期三）的研究報告中重申了對 Mesa Laboratories 股票的 “賣出（d）” 評級。最後，Zacks Research 在週四將 Mesa Laboratories 的評級上調至 “強烈賣出”。一位投資分析師對該股票給予了 “持有” 評級，兩位分析師對該股票給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Mesa Laboratories 目前的平均評級為 “賣出”，共識目標價為 67.00 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>獲取我們對 Mesa Laboratories 的最新股票分析</strong></p>
</div><h2>Mesa Laboratories Profile</h2>
<div class="lb-trans"><h2>Mesa Laboratories 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>Mesa Laboratories, Inc. 在北美、歐洲、亞太地區及國際上開發、設計、製造、銷售和服務生命科學工具及質量控制產品和服務。滅菌和消毒控制部門提供生物、化學和清潔指示劑，用於評估製藥、醫療器械和醫療行業中滅菌、去污、消毒和清潔過程的有效性。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>Differences Between Momentum Investing and Long Term Investing</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
<li>The Risks of Owning Bonds</li>
<li>Why Amazon Could Be a $300 Stock Within Weeks</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Mesa Laboratories</li>
<li>動量投資與長期投資的區別</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
<li>擁有債券的風險</li>
<li>為什麼亞馬遜可能在幾周內成為 300 美元的股票</li>
<li>即將到來的 IPO 股票鎖定期，解釋</li>
<li>Adobe 在財報後獲得提振：長期前景看好</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TUxBQg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=MLAB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Mesa Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Mesa Laboratories 嗎？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮投資 Mesa Laboratories 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前立即購買……而 Mesa Laboratories 並不在名單上。</p>
</div><p>While Mesa Laboratories currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Mesa Laboratories 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Ranger Investment Management L.P. 出售了 Mesa Laboratories, Inc. 的 $MLAB 股票